Vesalic at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

Vesalic brings 2 presentations to SfN 2026 in Washington. Its program at this meeting centres on ALS, extracellular vesicles, and disease models and biomarkers. One thread links systemic extracellular-vesicle pathology in a sporadic ALS mouse model with circulating vesicle lipids as biomarkers for tracking therapies.

OrganizationSfN 2026 Attendance
Vesalic
London, UK
vesalic.com
Drug developers
Early-stage biotech company developing therapies and biomarker-based diagnostics for ALS and other neurodegenerative diseases.
Poster
Wed Nov 18
8am–noon
Talk
Wed Nov 18
2:30–2:45pm

Explore the full SfN 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full SfN 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Vesalic

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction